IPSC
Price
$0.56
Change
+$0.01 (+1.82%)
Updated
Oct 14, 04:58 PM (EDT)
Capitalization
48.38M
22 days until earnings call
Intraday Buy/Sell Signals
SPRB
Price
$174.89
Change
+$15.88 (+9.99%)
Updated
Oct 14, 04:59 PM (EDT)
Capitalization
99.69M
33 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

IPSC vs SPRB

Header iconIPSC vs SPRB Comparison
Open Charts IPSC vs SPRBBanner chart's image
Century Therapeutics
Price$0.56
Change+$0.01 (+1.82%)
Volume$601
Capitalization48.38M
Spruce Biosciences
Price$174.89
Change+$15.88 (+9.99%)
Volume$3.1K
Capitalization99.69M
IPSC vs SPRB Comparison Chart in %
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPSC vs. SPRB commentary
Oct 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPSC is a Hold and SPRB is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 15, 2025
Stock price -- (IPSC: $0.55 vs. SPRB: $159.01)
Brand notoriety: IPSC and SPRB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPSC: 124% vs. SPRB: 23%
Market capitalization -- IPSC: $47.51M vs. SPRB: $89.6M
IPSC [@Biotechnology] is valued at $47.51M. SPRB’s [@Biotechnology] market capitalization is $89.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $104.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPSC’s FA Score shows that 0 FA rating(s) are green whileSPRB’s FA Score has 0 green FA rating(s).

  • IPSC’s FA Score: 0 green, 5 red.
  • SPRB’s FA Score: 0 green, 5 red.
According to our system of comparison, SPRB is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPSC’s TA Score shows that 6 TA indicator(s) are bullish while SPRB’s TA Score has 5 bullish TA indicator(s).

  • IPSC’s TA Score: 6 bullish, 4 bearish.
  • SPRB’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than SPRB.

Price Growth

IPSC (@Biotechnology) experienced а -0.97% price change this week, while SPRB (@Biotechnology) price change was +21.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.86%. For the same industry, the average monthly price growth was +14.21%, and the average quarterly price growth was +268.76%.

Reported Earning Dates

IPSC is expected to report earnings on Nov 06, 2025.

SPRB is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+0.86% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SPRB($99.7M) has a higher market cap than IPSC($48.4M). SPRB YTD gains are higher at: 41540.477 vs. IPSC (-44.554).
IPSCSPRBIPSC / SPRB
Capitalization48.4M99.7M49%
EBITDA-6.16MN/A-
Gain YTD-44.55441540.477-0%
P/E RatioN/AN/A-
Revenue114MN/A-
Total Cash156MN/A-
Total Debt51.5MN/A-
TECHNICAL ANALYSIS
Technical Analysis
IPSCSPRB
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Momentum
ODDS (%)
Bullish Trend 7 days ago
76%
Bullish Trend 7 days ago
77%
MACD
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 7 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 7 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 8 days ago
78%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 13 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bullish Trend 7 days ago
81%
Bearish Trend 7 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SPRB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CYTK61.031.44
+2.42%
Cytokinetics
OMCL29.690.23
+0.78%
Omnicell
GOOGL245.451.30
+0.53%
Alphabet
HYAC11.310.01
+0.07%
Haymaker Acquisition Corp
LTRN4.36-0.05
-1.13%
Lantern Pharma

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
+1.84%
CRSP - IPSC
54%
Loosely correlated
+1.57%
IMNM - IPSC
53%
Loosely correlated
-1.26%
ARWR - IPSC
50%
Loosely correlated
-0.80%
CABA - IPSC
49%
Loosely correlated
+15.86%
FATE - IPSC
49%
Loosely correlated
+7.91%
More

SPRB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SPRB has been closely correlated with JBIO. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if SPRB jumps, then JBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPRB
1D Price
Change %
SPRB100%
+9.99%
JBIO - SPRB
74%
Closely correlated
+0.55%
IMRX - SPRB
52%
Loosely correlated
-2.77%
ENTBF - SPRB
38%
Loosely correlated
N/A
IMCR - SPRB
38%
Loosely correlated
-2.01%
IPSC - SPRB
36%
Loosely correlated
+1.84%
More